Compare KVUE & TGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KVUE | TGT |
|---|---|---|
| Founded | 2022 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Department/Specialty Retail Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9B | 41.7B |
| IPO Year | 2023 | N/A |
| Metric | KVUE | TGT |
|---|---|---|
| Price | $17.33 | $97.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 27 |
| Target Price | $20.31 | ★ $101.04 |
| AVG Volume (30 Days) | ★ 37.7M | 7.9M |
| Earning Date | 11-03-2025 | 11-19-2025 |
| Dividend Yield | ★ 4.79% | 4.70% |
| EPS Growth | ★ 35.31 | N/A |
| EPS | 0.75 | ★ 8.25 |
| Revenue | $15,006,000,000.00 | ★ $105,242,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.81 | $1.77 |
| P/E Ratio | $23.18 | ★ $11.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.02 | $83.44 |
| 52 Week High | $25.17 | $145.08 |
| Indicator | KVUE | TGT |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 66.48 |
| Support Level | $16.70 | $90.17 |
| Resistance Level | $17.59 | $92.91 |
| Average True Range (ATR) | 0.31 | 2.40 |
| MACD | 0.03 | 0.94 |
| Stochastic Oscillator | 76.29 | 92.18 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Target's start dates back to 1962, but now it is one of the largest discount retailers in the United States (where it derives all of its sales), operating just under 2,000 stores and generating over $106 billion in fiscal 2024 sales. The company offers a broad assortment of merchandise across categories including apparel and accessories (16% of fiscal 2024 revenue), beauty and household essentials (30%), food and beverage (23%), hardlines (15%), as well as home furnishings (16%). Target's model is anchored in its physical store base, which fulfills more than 97% of sales. Around 30% of sales are derived from its own private-label brands.